Allison Nixon

Director of Platform Sciences, Ability Biologics

BiotechTorontoOn TechTO stages since 2018

Allison Nixon is a molecular geneticist (PhD, University of Toronto) working in AI-driven drug discovery. She was an early platform-sciences scientist at Toronto biotech Phenomic AI and is now Director of Platform Sciences at Ability Biologics. She spoke at TechTO's HealthTO in 2018 on lessons from academia to biotech.

On the TechTO stage ×1

TECHTO9:00

Allison Nixon of Phenomic AI presents Lessons from the boonies to biotech

TechTO · June 2018

Watch on YouTube ↗

First seen on the TechTO stage in 2018. Every talk is searchable — ask the archive about Allison ↗

In their words

the lesson here is that you don't have all the answers yourself

TechTO, Jun 2018 · watch at 02:11 ↗

building the right team I didn't do anything in my academic lab all by myself I built collaborations with other labs

TechTO, Jun 2018 · watch at 04:27 ↗

A few quotes can’t cover everything Allison said on the TechTO stage. 1,600+ talks are searchable.Ask about Allison ↗

Quick answers

What is Allison Nixon known for?

Molecular genetics and platform science in AI-driven drug discovery. She was an early scientist at Phenomic AI and is now Director of Platform Sciences at Ability Biologics.

Did Allison Nixon found Phenomic AI?

No. She joined Phenomic AI as an early platform-sciences scientist; the company's founder and CEO is Sam Cooper.

Suggest an edit

What’s wrong, and what should it say?Source that backs it up (link, optional)Your email (optional — only if you want a reply)Send suggestion

This is you? Claim this profileAsk to be removed

Know someone who belongs here? Suggest a profile

Who? (person or company)Why do they belong in the Canadian tech ecosystem directory?Links that help (talk, site, LinkedIn — optional)Your email (optional)Suggest this profile

Maintained by TechTO · facts sourced and dated · last reviewed Jul 18, 2026